Immunomodulatory effects ofB cell derivedVEGF-A in mice

B细胞来源的VEGF-A对小鼠的免疫调节作用

基本信息

  • 批准号:
    22390179
  • 负责人:
  • 金额:
    $ 11.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2010
  • 资助国家:
    日本
  • 起止时间:
    2010 至 2012
  • 项目状态:
    已结题

项目摘要

Vascular endothelial growth factor A (VEGF-A) is a prominent growth factor for both angiogenesis and lymphangiogenesis. Recentstudies have shown the importance of VEGF-A in enhancing the growth of lymphatic endothelial cells in lymph nodes (LNs) and the migration of dendritic cells into LNs. VEGF-A is produced in inflamed tissues and/or in draining LNs, where B cells are a possible source of this growth factor. To study the effect of B cell-derived VEGF-A, we created transgenic mice (CD19Cre/hVEGF-Afl) that express human VEGF-A specifically in B cells. We found that the human VEGF-A produced by B cells not only induced lymphangiogenesis in LNs, but also induced the expansion of LNs and the development of high endothelial venules. Contrary to our expectation, we observed a significant decrease in the Ag-specific Ab production postimmunization with OVA and in the proinflammatory cytokine production postinoculation with LPS in these mice. Our findings suggest immunomodulatory effects of VEGF-A: B cell-derived VEGF-A promotes both lymphangiogenesis and angiogenesis within LNs, but then suppresses certain aspects of the ensuing immune responses. 交付決定額
Vascular endothelial growth factor A (VEGF-A) is a prominent growth factor for both angiogenesis and lymphangiogenesis. Recent studies have shown the importance of VEGF-A in enhancing the growth of lymphatic endothelial cells in lymph nodes (LNs) and the migration of dendritic cells into LNs. VEGF-A is produced in inflamed tissues and/or in draining LNs, where B cells are a possible source of this growth factor. To study the effect of B cell-derived VEGF-A, we created transgenic mice (CD19Cre/hVEGF-Afl) that express human VEGF-A specifically in B cells. We found that the human VEGF-A produced by B cells not only induced lymphangiogenesis in LNs, but also induced the expansion of LNs and the development of high endothelial venules. Contrary to our expectation, we observed a significant decrease in the Ag-specific Ab production postimmunization with OVA and in the proinflammatory cytokine production postinoculation with LPS in these mice. Our findings suggest immunomodulatory effects of VEGF-A: B cell-derived VEGF-A promotes both lymphangiogenesis and angiogenesis within LNs, but then suppresses certain aspects of the ensuing immune responses. Delivery Determination

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intravitreous VEGF-A in eyes with massive vitreous hemorrhage
Advanced malignant melanoma responds to Prunus mume Sieb. Et Zucc (Ume) extract: Case report and in vitro study
  • DOI:
    10.3892/etm_00000089
  • 发表时间:
    2010-07-01
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Matsushita, Shigeto;Tada, Ko-Ichi;Kanekura, Takuro
  • 通讯作者:
    Kanekura, Takuro
Quantitative analysis of biofilm formation of methicillin-resistant Staphylococcus aureus (MRSA) strains from patients with orthopaedic device-related infections
  • DOI:
    10.1111/j.1574-695x.2011.00821.x
  • 发表时间:
    2011-10-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kawamura, Hideki;Nishi, Junichiro;Komiya, Setsuro
  • 通讯作者:
    Komiya, Setsuro
Effectiveness of esophagus detection by three-dimensional electroanatomical mapping to avoid esophageal injury during ablation of atrial fibrillation.
通过三维电解剖测绘检测食管的有效性,以避免房颤消融过程中食管损伤。
  • DOI:
    10.1016/j.jjcc.2012.02.009
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Horie S;Yamasaki T;Okamoto T;Kan S;Ogata K;Miyauchi S;Tobimatsu S.;Maenosono R
  • 通讯作者:
    Maenosono R
Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease
  • DOI:
    10.3892/or.2011.1425
  • 发表时间:
    2011-11-01
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Oda, Kohei;Ido, Akio;Tsubouchi, Hirohito
  • 通讯作者:
    Tsubouchi, Hirohito
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HASHIGUCHI Teruto其他文献

HASHIGUCHI Teruto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HASHIGUCHI Teruto', 18)}}的其他基金

Contribution of vascular permeability for aging erythrocyte selection in spleen
血管通透性对脾脏中衰老红细胞选择的贡献
  • 批准号:
    24659282
  • 财政年份:
    2012
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Diagnostic value of peptidome analyses for protease activated pathological conditions beyond cancer diagnosis
肽组分析对癌症诊断之外的蛋白酶激活病理状况的诊断价值
  • 批准号:
    19390156
  • 财政年份:
    2007
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Proteomic analysis of Crow-Fukase syndrome
Crow-Fukase 综合征的蛋白质组学分析
  • 批准号:
    17590888
  • 财政年份:
    2005
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of the unknown factor over stimulating the VEGF prodution in Crow-Fukase syndrome.
Crow-Fukase 综合征中过度刺激 VEGF 产生的未知因素的调查。
  • 批准号:
    15590901
  • 财政年份:
    2003
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proposal of the new concept, "Platelet VEGF"
提出新概念“血小板VEGF”
  • 批准号:
    13670659
  • 财政年份:
    2001
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

VEGF驱动的T细胞耗竭异质性影响左右半结肠癌靶向与免疫联合治疗敏感性的分子机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
抗 PD-1 和 VEGF 双特异性抗体 AK112 联合紫杉醇胶束逆转晚期胃癌免疫治疗耐药机制研究
  • 批准号:
    2023JJ60335
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
拮抗VEGF和PD-L1的仿生纳米囊泡用于肝癌免疫治疗的研究
  • 批准号:
    2022J011282
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
从 VEGF-A 串扰肿瘤血管生成与免疫微环境探讨艾灸对胃癌的抑制作用
  • 批准号:
    2022JJ40306
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
TCR激活触发的VEGF-B自分泌在调控CD8+T细胞脂质代谢与抗肿瘤免疫中的作用
  • 批准号:
    32270967
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
PAARH通过VEGF促进M2型巨噬细胞极化及肝癌细胞免疫逃逸的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
化瘀丸通过VEGF靶点诱导肿瘤血管正常化联合免疫检查点抑制剂干预三阴性乳腺癌转移机理研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
血管内皮生长因子VEGF-B调控T细胞脂肪酸代谢与免疫功能的作用与机制
  • 批准号:
    22ZR1435700
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
VEGF和TGF-β双特异性抗体重塑免疫微环境及协同PD-L1抗体的抑癌作用研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
基于VEGF、ETBR和PD-L1联合靶点研究健脾化瘀法抗血管生成恢复T细胞免疫活性治疗胃癌的物质基础和分子机制
  • 批准号:
    82205318
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

抗VEGF抗体による腫瘍免疫活性化の包括的解析に基づく免疫治療創出を目指した研究
研究旨在基于抗 VEGF 抗体对肿瘤免疫激活的综合分析来创建免疫疗法
  • 批准号:
    22K15505
  • 财政年份:
    2022
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
通过共同靶向 VEGF 和 Ang2 重新编程肿瘤微环境以改善胶质母细胞瘤的免疫治疗
  • 批准号:
    10582613
  • 财政年份:
    2021
  • 资助金额:
    $ 11.9万
  • 项目类别:
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
通过共同靶向 VEGF 和 Ang2 重新编程肿瘤微环境以改善胶质母细胞瘤的免疫治疗
  • 批准号:
    10394968
  • 财政年份:
    2021
  • 资助金额:
    $ 11.9万
  • 项目类别:
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
可切除 HCC 患者新辅助治疗中双重 VEGF/PD-L1 阻断的 II 期和生物标志物研究
  • 批准号:
    10379391
  • 财政年份:
    2021
  • 资助金额:
    $ 11.9万
  • 项目类别:
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
可切除 HCC 患者新辅助治疗中双重 VEGF/PD-L1 阻断的 II 期和生物标志物研究
  • 批准号:
    10614487
  • 财政年份:
    2021
  • 资助金额:
    $ 11.9万
  • 项目类别:
Suprachoroidal nonviral gene transfer of engineered VEGF antagonists
工程 VEGF 拮抗剂的脉络膜上非病毒基因转移
  • 批准号:
    10557124
  • 财政年份:
    2020
  • 资助金额:
    $ 11.9万
  • 项目类别:
Suprachoroidal nonviral gene transfer of engineered VEGF antagonists
工程 VEGF 拮抗剂的脉络膜上非病毒基因转移
  • 批准号:
    10093050
  • 财政年份:
    2020
  • 资助金额:
    $ 11.9万
  • 项目类别:
Use of skin grafts programmed to express VEGF-C with biosensor feedback regulation to treat lymphedema
使用编程表达 VEGF-C 并具有生物传感器反馈调节的皮肤移植来治疗淋巴水肿
  • 批准号:
    10042514
  • 财政年份:
    2020
  • 资助金额:
    $ 11.9万
  • 项目类别:
Mechanism of action of VEGF in immune suppression: Difference between normal and tumor immunity
VEGF在免疫抑制中的作用机制:正常免疫与肿瘤免疫的差异
  • 批准号:
    20K16553
  • 财政年份:
    2020
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Use of skin grafts programmed to express VEGF-C with biosensor feedback regulation to treat lymphedema
使用编程表达 VEGF-C 并具有生物传感器反馈调节的皮肤移植来治疗淋巴水肿
  • 批准号:
    10249235
  • 财政年份:
    2020
  • 资助金额:
    $ 11.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了